To prevent low-dose aspirin induced peptic ulcers, which is better the use of proton pump inhibitors or histamine type2 receptor agonist; randomized controlled trial.

Trial Profile

To prevent low-dose aspirin induced peptic ulcers, which is better the use of proton pump inhibitors or histamine type2 receptor agonist; randomized controlled trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Famotidine (Primary) ; Lansoprazole (Primary)
  • Indications NSAID-induced ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jul 2017 Status changed from not yet recruiting to discontinued.
    • 11 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top